The unmet need for COVID-19 treatment in immunocompromised patients
Abstract Background Immunocompromised (IC) patients are at increased risk of severe and/or prolonged COVID-19. Main text The recent study by Scaglione et al., addresses the issue of IC outpatients with SARS-CoV-2 infection. Authors describe the real-life use of SARS-CoV-2 antivirals and/or monoclona...
Main Authors: | D’Abramo Alessandra, Vita Serena, Nicastri Emanuele |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07918-x |
Similar Items
-
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
by: Daniele Focosi, et al.
Published: (2023-12-01) -
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
by: Serena Vita, et al.
Published: (2024-02-01) -
Correction: The unmet need for COVID-19 treatment in immunocompromised patients
by: Alessandra D’Abramo, et al.
Published: (2023-01-01) -
Management of viral infections in immunocompromised cancer patients
by: Swiss Medical Weekly
Published: (2002-07-01) -
Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
by: Karrie K. K. Ko, et al.
Published: (2022-06-01)